Diarrheal syndrome; report on therapy using resion with polymyxin and phthalylsulfacetamide.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003106:Colon; D003110:Colonic Neoplasms; D003879:Dermatologic Agents; D003967:Diarrhea / Q000628:therapy*; D005765:Gastrointestinal Agents; D006801:Humans; D007475:Ion Exchange Resins / Q000627:therapeutic use*; D009369:Neoplasms; D011113:Polymyxins; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D005765:Gastrointestinal Agents; D007475:Ion Exchange Resins; D011113:Polymyxins; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide
ANTIBIOTICS/therapeutic use; COLON/neoplasms; DIARRHEA/therapy; ION EXCHANGE RESINS/therapeutic use; SULFONAMIDES/therapeutic use